[144] Confluent, Inc. SEC Filing

Rhea-AI Filing Summary

Confluent, Inc. (CFLT) Form 144 notice: The filer proposes to sell 30,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $565,500, and an approximate sale date of 08/28/2025 on NASDAQ. The filing reports 291,931,187 shares outstanding. The shares were acquired as an in-kind distribution post IPO on 09/16/2014. The filing also discloses recent 10b5-1 sales in the past three months: 15,000 shares for $375,000 and 476 shares for $11,900 on 06/05/2025. The signer represents no knowledge of undisclosed material adverse information and, if applicable, cites reliance on a Rule 10b5-1 plan.

Insights

Securities Analyst

TL;DR Routine Form 144 reporting a proposed sale of restricted shares; prior 10b5-1 activity shown.

The filing documents a planned sale of 30,000 common shares valued at $565,500 to be executed through Morgan Stanley Smith Barney with an approximate sale date of 08/28/2025. The shares were acquired in-kind post-IPO on 09/16/2014. The filing includes recent 10b5-1 transactions on 06/05/2025 totaling 15,476 shares with gross proceeds of $386,900. For investors, this is a disclosure of insider-related selling activity; the form contains no operational or financial performance data.

Corporate Governance Expert

TL;DR Clear Rule 144 notice and 10b5-1 disclosure; signer affirms absence of undisclosed material information.

The notice provides required information about the proposed sale, broker, acquisition date, and previous 10b5-1 sales by related trusts. It reiterates the statutory representation that the seller is not aware of any undisclosed material adverse information. The filing is procedural and consistent with regulatory obligations for reported insider sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	30000	565500.00	291931187	08/28/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/16/2014	In-kind distribution post IPO	Issuer			30000	09/16/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for THE VISHRIA REVOCABLE TRUST 899 W. EVELYN AVENUE MOUNTAIN VIEW CA 94041	Common	06/05/2025	15000	375000.00
10b5-1 Sales for THE KHAKAL TRUST 899 W. EVELYN AVENUE MOUNTAIN VIEW CA 94041	Common	06/05/2025	476	11900.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Confluent (CFLT) report in this Form 144?

The filer proposes to sell 30,000 common shares valued at $565,500 through Morgan Stanley Smith Barney with an approximate sale date of 08/28/2025.

When and how were the shares to be sold acquired?

The shares were acquired on 09/16/2014 as an in-kind distribution post IPO from the issuer.

Were there any related sales in the past three months?

Yes. 10b5-1 sales on 06/05/2025 include 15,000 shares for $375,000 and 476 shares for $11,900 by named trusts.

How many Confluent shares are outstanding per the filing?

The filing reports 291,931,187 shares outstanding.

Does the filer attest to any undisclosed material information?

Yes. The person for whose account the securities are to be sold represents they do not know any material adverse information about the issuer that has not been publicly disclosed.